These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35973112)

  • 1. Self-Assembled Immunostimulatory Tetrahedral Framework Nucleic Acid Vehicles for Tumor Chemo-immunotherapy.
    Liu M; Hao L; Zhao D; Li J; Lin Y
    ACS Appl Mater Interfaces; 2022 Aug; 14(34):38506-38514. PubMed ID: 35973112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crizotinib prodrug micelles co-delivered doxorubicin for synergistic immunogenic cell death induction on breast cancer chemo-immunotherapy.
    Liang Q; Lan Y; Li Y; Cao Y; Li J; Liu Y
    Eur J Pharm Biopharm; 2022 Aug; 177():260-272. PubMed ID: 35863668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
    Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
    ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronidase-Functionalized Silica Nanocarrier for Enhanced Chemo-Immunotherapy through Inducing Immunogenic Cell Death.
    Liu Q; Sun Y; Yin X; Li J; Xie J; Xie M; Wang K; Wu S; Li Y; Hussain M; Jiang B; Liu Y; Huang C; Tao J; Zhu J
    ACS Appl Bio Mater; 2020 May; 3(5):3378-3389. PubMed ID: 35025380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolving microneedles-based programmed delivery system for enhanced chemo-immunotherapy of melanoma.
    Tian Y; Jing H; Wang Q; Hu S; Wu Z; Duan Y
    J Control Release; 2023 Aug; 360():630-646. PubMed ID: 37414221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
    Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
    Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
    Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
    Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
    Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo-immunotherapy.
    Jiang M; Zeng J; Zhao L; Zhang M; Ma J; Guan X; Zhang W
    Nanoscale; 2021 Oct; 13(41):17218-17235. PubMed ID: 34643196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy.
    Ma B; Ma Y; Deng B; Xiao P; Huang P; Wang D; Liu L
    J Nanobiotechnology; 2023 May; 21(1):171. PubMed ID: 37237292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy.
    Ma X; Yang S; Zhang T; Wang S; Yang Q; Xiao Y; Shi X; Xue P; Kang Y; Liu G; Sun ZJ; Xu Z
    Acta Pharm Sin B; 2022 Jan; 12(1):451-466. PubMed ID: 35127398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charge reversal yolk-shell liposome co-loaded JQ1 and doxorubicin with high drug loading and optimal ratio for synergistically enhanced tumor chemo-immunotherapy via blockade PD-L1 pathway.
    Liu D; Li K; Gong L; Fu L; Yang D
    Int J Pharm; 2023 Mar; 635():122728. PubMed ID: 36796659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
    He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergizing autophagic cell death and oxaliplatin-induced immunogenic death by a self-delivery micelle for enhanced tumor immunotherapy.
    Deng T; Chen D; Chen F; Xu C; Zhang Q; Li M; Wang Y; He Z; Li M; He Q
    Acta Biomater; 2024 Dec; 190():548-559. PubMed ID: 39426655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Liposomal Co-delivery of an Immunogenic Cell Death Inducer and a Toll-Like Receptor 4 Agonist for Enhanced Cancer Chemo-immunotherapy.
    Park H; Lee S; Son MK; Kang I; Surwase SS; Song YG; Lee HK; Lee YK; Kim YC
    ACS Appl Mater Interfaces; 2024 Aug; 16(32):41810-41818. PubMed ID: 39084852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tumor extracellular pH-sensitive PD-L1 binding peptide nanoparticle for chemo-immunotherapy of cancer.
    Zhu W; Bai Y; Zhang N; Yan J; Chen J; He Z; Sun Q; Pu Y; He B; Ye X
    J Mater Chem B; 2021 May; 9(20):4201-4210. PubMed ID: 33997867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy.
    Zhao X; Yang K; Zhao R; Ji T; Wang X; Yang X; Zhang Y; Cheng K; Liu S; Hao J; Ren H; Leong KW; Nie G
    Biomaterials; 2016 Sep; 102():187-97. PubMed ID: 27343466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Framework Nucleic Acid Immune Adjuvant for Transdermal Delivery Based Chemo-immunotherapy for Malignant Melanoma Treatment.
    Shen F; Sun L; Wang L; Peng R; Fan C; Liu Z
    Nano Lett; 2022 Jun; 22(11):4509-4518. PubMed ID: 35594186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model.
    Merino M; Lozano T; Casares N; Lana H; Troconiz IF; Ten Hagen TLM; Kochan G; Berraondo P; Zalba S; Garrido MJ
    J Nanobiotechnology; 2021 Apr; 19(1):102. PubMed ID: 33849551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of doxorubicin and STING agonist cGAMP for enhanced antitumor immunity.
    Xie Y; Li K; Liang J; Wang K; Gong Z; Chen X
    Int J Pharm; 2024 Apr; 654():123955. PubMed ID: 38423155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.